Speaker Vicky Whittemore from NIH, status of research : overview at NIH #mecfs and #LongCovid research
#NIH trans NIH #MECFS research institute - nih.gov/mecfs to sign up for alerts to watch quarterly briefings.
goals: foster communication between federal agencies on issues related to mecfs. funding for mecfs started to raise in 2016, there is a dip in 2022 because the 3 research centers not funded that year, expected to be funded in 2024
Phenotyping studies for #MECFS , #longcovid and gulf war veterans are undergoing.
Cornell mecfs collaborative research center has just been funded to look at the underlying mechanisms of #MECFS
Search #MECFS is a tool where researches can look for bio specimens that are available to be used for their research study.
#MECFS research: cell-cell interaction, metabolism, age, length of illness, proteome, cytokines, infection, sex as a biological variable, extracellular vesicles, acetyl-coA pathway, propionate, are just some of the areas of research stratification in current studies
Evaluating epidemiology and determinants of neurologic #longcovid comparative to #MECFS
An #MECFS research roadmap is being developed. Special thanks to Richard Simpson and Simon Carding for participating in the working group council.
21 individuals in the group focus on: nervous system, genetics, immune system, metabolism, circulatory system, physiology, chronic infection. Sign up for the webinar to get updates on where this groups are focusing in terms of research. the objective is to move into action
The working group's 2nd conference will take place December 11-13, 2023, this will include tragets for interventions and learning from #LongCovid
studies.recovercovid.org - as of may 26, 2023 recover observational studies have enrolled over 26k pts. Focus areas: viral persistence, autonomic dysfunction, cognitive dysfunction, exercise intolerance and fatigue, sleep disturbances.
The protocol is being reconsidered in regards to the exercise portion of the trial because of the outcry from patients. These issues are being reconsidered.
There is a meeting at the end of this month to come to a better definition of #LongCovid and hopefully use a standardize those definitions among agencies.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
All of them are risk factors and we need to understand the interrelationships of complex disease and the possibilities for differentiated treatment by patient stratification. Biomarkers remain elusive and clinical subtypes need phenotype & system biology approach
We have just started to define the edges of the puzzle, we need to be able to complete the puzzle by understanding the big picture and what pieces are the components.
How do you determine molecular cause of MECFS and how do you treat and cure it ?
There are many crossroads in the maze of trying to treat MECFS. The decision taken had to do with the experience and perception of the person taking the decision
Before MECFS: a virus, bacteria, physical trauma, childbirth, vaccination, surgery.
TCA cycle - itaconate not discussed prevalently within this cycle. The transformation with CoA-SH was believed to be the end of that part of the process.
Every carbon is avoiding the processes that lead to NAD. The shunt will reduce the amount of ATP depending on the amount of carbon going in the different directions.
Dr Jesper Mehlsen - Towards a uniform treatment regimen
There is knowledge in the Pathobiology of MECFS - using that to direct treatment
Neuro inflammation and human herpes virus - removal of EBV, cmv, hhv6. ; also decrease inflammation with mono/doxy (#remissionbiome ), LDN, aripripazol, SSRI, PEA, cox 2 inhibitors; ATR1 blockers - not one size fits all